Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Feldt-Rasmussen

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
Acta Endocrinologica (Bucharest, Romania : 2005)|June 1, 2019
THE ROMANIAN VERSION OF THE THYROID-RELATED PATIENT-REPORTED OUTCOMES THYPRO AND THYPRO-39. TRANSLATION AND ASSESSMENT OF RELIABILITY AND CROSS-CULTURAL VALIDITYA E Zahan, T Watt, I Pascanu, et al.
The Journal of Endocrinology|October 1, 1996
Interleukin-1 beta inhibits rat thyroid cell function in vivo and in vitro by an NO-independent mechanism and induces hypothyroidism and accelerated thyroiditis in diabetes-prone BB ratsJ I Reimers, A K Rasmussen, A E Karlsen, et al.
Endocrine|September 25, 2018
Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomideD Bengtsson, H D Schrøder, K Berinder, et al.
Clinical Endocrinology|August 10, 2000
Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid noduleL Christensen, M Blichert-Toft, M Brandt, et al.
Chronobiology International|November 29, 2017
Decrease in scale invariance of activity fluctuations with aging and in patients with suprasellar tumorsS D Joustra, C Gu, J H T Rohling, et al.
Endocrine Connections|January 25, 2018
Maternal exposure to UV filters: associations with maternal thyroid hormones, IGF-I/IGFBP3 and birth outcomesM Krause, H Frederiksen, K Sundberg, et al.
Annales De Biologie Clinique|January 1, 1996
Human thyroglobulin reference material (CRM 457). 1st Part: Assessment of homogeneity, stability and immunoreactivityU Feldt-Rasmussen, C Profilis, E Colinet, et al.
Annales De Biologie Clinique|January 1, 1996
Human thyroglobulin reference material (CRM 457). 2nd Part: Physicochemical characterization and certificationU Feldt-Rasmussen, C Profilis, E Colinet, et al.
European Journal of Endocrinology|December 22, 1999
Multicenter study on TGPO autoantibody prevalence in various thyroid and non-thyroid diseases; relationships with thyroglobulin and thyroperoxidase autoantibody parametersV Estienne, C Duthoit, V D Costanzo, et al.
Molecular Genetics and Metabolism|March 1, 2021
Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensusD Moreno-Martinez, P Aguiar, C Auray-Blais, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
Acta Endocrinologica (Bucharest, Romania : 2005)|June 1, 2019
THE ROMANIAN VERSION OF THE THYROID-RELATED PATIENT-REPORTED OUTCOMES THYPRO AND THYPRO-39. TRANSLATION AND ASSESSMENT OF RELIABILITY AND CROSS-CULTURAL VALIDITYA E Zahan, T Watt, I Pascanu, et al.
The Journal of Endocrinology|October 1, 1996
Interleukin-1 beta inhibits rat thyroid cell function in vivo and in vitro by an NO-independent mechanism and induces hypothyroidism and accelerated thyroiditis in diabetes-prone BB ratsJ I Reimers, A K Rasmussen, A E Karlsen, et al.
Endocrine|September 25, 2018
Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomideD Bengtsson, H D Schrøder, K Berinder, et al.
Clinical Endocrinology|August 10, 2000
Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid noduleL Christensen, M Blichert-Toft, M Brandt, et al.
Chronobiology International|November 29, 2017
Decrease in scale invariance of activity fluctuations with aging and in patients with suprasellar tumorsS D Joustra, C Gu, J H T Rohling, et al.
Endocrine Connections|January 25, 2018
Maternal exposure to UV filters: associations with maternal thyroid hormones, IGF-I/IGFBP3 and birth outcomesM Krause, H Frederiksen, K Sundberg, et al.
Annales De Biologie Clinique|January 1, 1996
Human thyroglobulin reference material (CRM 457). 1st Part: Assessment of homogeneity, stability and immunoreactivityU Feldt-Rasmussen, C Profilis, E Colinet, et al.
Annales De Biologie Clinique|January 1, 1996
Human thyroglobulin reference material (CRM 457). 2nd Part: Physicochemical characterization and certificationU Feldt-Rasmussen, C Profilis, E Colinet, et al.
European Journal of Endocrinology|December 22, 1999
Multicenter study on TGPO autoantibody prevalence in various thyroid and non-thyroid diseases; relationships with thyroglobulin and thyroperoxidase autoantibody parametersV Estienne, C Duthoit, V D Costanzo, et al.
Molecular Genetics and Metabolism|March 1, 2021
Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensusD Moreno-Martinez, P Aguiar, C Auray-Blais, et al.
Pageof 20